Mathai Mammen - Net Worth and Insider Trading
Mathai Mammen Net Worth
The estimated net worth of Mathai Mammen is at least $3 Million dollars as of 2024-11-13. Mathai Mammen is the Director of 10x Genomics Inc and owns about 169,745 shares of 10x Genomics Inc (TXG) stock worth over $3 Million. Details can be seen in Mathai Mammen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mathai Mammen has not made any transactions after 2023-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mathai Mammen
Mathai Mammen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mathai Mammen owns 4 companies in total, including 10x Genomics Inc (TXG) , Theravance Biopharma Inc (TBPH) , and Innoviva Inc (INVA) among others .
Click here to see the complete history of Mathai Mammen’s form 4 insider trades.
Insider Ownership Summary of Mathai Mammen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TXG | 10x Genomics Inc | 2023-05-11 | director |
TBPH | Theravance Biopharma Inc | 2014-10-01 | SVP & Research & Early Clin Dev |
INVA | Innoviva Inc | 2008-01-04 | Senior VP & Research |
2022-01-03 | EVP & Pharm & R&D |
Mathai Mammen Latest Holdings Summary
Mathai Mammen currently owns a total of 1 stock. Mathai Mammen owns 169,745 shares of 10x Genomics Inc (TXG) as of May 11, 2023, with a value of $3 Million.
Latest Holdings of Mathai Mammen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TXG | 10x Genomics Inc | 2023-05-11 | 169,745 | 15.70 | 2,664,997 |
Holding Weightings of Mathai Mammen
Mathai Mammen Form 4 Trading Tracker
According to the SEC Form 4 filings, Mathai Mammen has made a total of 1 transactions in 10x Genomics Inc (TXG) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 10x Genomics Inc is the sale of 33,000 shares on May 11, 2023, which brought Mathai Mammen around $2 Million.
Insider Trading History of Mathai Mammen
- 1
Mathai Mammen Trading Performance
Mathai Mammen Ownership Network
Ownership Network List of Mathai Mammen
Ownership Network Relation of Mathai Mammen
Mathai Mammen Owned Company Details
What does 10x Genomics Inc do?
Who are the key executives at 10x Genomics Inc?
Mathai Mammen is the director of 10x Genomics Inc. Other key executives at 10x Genomics Inc include director & 10 percent owner & Chief Executive Officer Serge Saxonov , director & See Remarks Benjamin J. Hindson , and Chief Financial Officer Justin J. Mcanear .
10x Genomics Inc (TXG) Insider Trades Summary
Over the past 18 months, Mathai Mammen made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 93,946 shares made by Serge Saxonov , a net sale of 41,247 shares made by Benjamin J. Hindson , and a net sale of 12,784 shares made by Justin J. Mcanear .
In summary, during the past 3 months, insiders sold 14,061 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 14,061 shares. During the past 18 months, 186,174 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,174 shares.
10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.
10x Genomics Inc Insider Transactions
Mathai Mammen Mailing Address
Above is the net worth, insider trading, and ownership report for Mathai Mammen. You might contact Mathai Mammen via mailing address: Theravance,inc., 901 Gateway Blvd., South San Francisco Ca 94080.